A Chinese medicine composition for treating abnormal blocking antibodies and its pharmaceutical preparation and application
Through the combination of traditional Chinese medicine compositions such as Eucommia ulmoides and Rehmannia, it is prepared into a medicine to warm the kidneys and strengthen the spleen, nourish the qi and nourish the blood, solve the problems of the existing methods of treating abnormal closed antibodies with large side effects and poor efficacy, and achieve high efficiency and safety The therapeutic effect is 94%.
Patent Information
- Application Number
- CN202410196518.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-02-22
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-02-22
AI Technical Summary
The existing habitual miscarriage methods caused by blocking antibody abnormalities have the risk of cross-infection and have great side effects, and are not effective, so they cannot effectively regulate the patient's immune response.
A Chinese medicine composition is adopted, including Eucommia ulmoides, Rehmannia, Cuscuta chinensis, Xianlings, Angelica sinensis, roasted Astragalus, Chuanxiong and Perilla stems, which are regulated by warming the kidneys and strengthening the spleen, nourishing qi and blood, regulating Chongren, promoting qi and promoting blood circulation, The patient's immune response is prepared into commonly used dosage forms such as granules and tablets, which are used to treat blocking antibody abnormalities.
The traditional Chinese medicine composition has few side effects, significant efficacy, and an effective efficiency of 94%. It provides a safe and effective treatment plan for habitual miscarriage caused by abnormal blocking antibodies, reducing the risk of miscarriage.
Smart Images

Figure BDA0004709881600000051
Abstract
Description
Technical Field
[0001] The present invention relates to the field of Chinese medicine compositions, and in particular to a Chinese medicine composition and a pharmaceutical preparation thereof for treating abnormal blocking antibodies. Background Art
[0002] Recurrent spontaneous abortion (RSA) refers to the phenomenon of spontaneous abortion in the same gestational week for two consecutive pregnancies, which is a common complication in obstetrics and gynecology. Such patients often experience multiple pregnancies and multiple abortions, and some patients even have 7-8 abortions. In the past, due to the unclear etiology of RSA caused by immune factors and no effective classification method, clinicians often gave this type of RSA the so-called fetal preservation treatment with Chinese medicine, progesterone or chorionic gonadotropin, but because the etiology was unclear, the treatment effect can be imagined. With the continuous deepening of reproductive immunology research, people have a new understanding of many difficult problems of pregnancy immunity and immune RSA. Studies have found that the lack or abnormality of blocking antibodies is the main cause of habitual abortion. Normal pregnant women have an antibody that protects the fetus in their bodies - blocking antibodies. Due to the lack of this antibody, RSA cannot protect the embryo after pregnancy and is rejected by the mother, leading to abortion.
[0003] The blocking antibodies in normal pregnant women's serum are mainly produced by human leukocyte antigens (HLA) on the surface of the embryo and lymphocyte cross-reactive antigens (TLX) mainly expressed in the trophoblast. They can prevent the paternal antigens of the embryo from being recognized and killed by the maternal immune system by binding to the corresponding antigens, thereby maintaining pregnancy. At present, the main method to determine the abnormality of blocking antibodies is to detect the antigen response of the patient's serum blocking antibodies to the CD3, CD4, and CD8 antigens of the spouse's peripheral blood T lymphocytes. Studies have shown that if the trophoblast cells cannot effectively express the CD3-related TLX antigens, the physiological stimulation of the CD3 antigen is weakened. The CD3 antigen has an enhanced activation effect on the internal conduction signal of T cells, which is conducive to the establishment of a normal maternal-fetal immune regulatory network; the CD4 antigen can enhance the binding of TCR-CD3 to the major histocompatibility antigen system (MHC)-II class antigens, and the CD8 antigen helps to mediate the damage of cytotoxic T cells to target antigens.
[0004] At present, the main treatment for blocking antibody deficiency is active immunotherapy, which is to extract lymphocytes from the patient's spouse and inject them into the patient's skin at multiple points to produce antibodies that protect the embryo from immune attack. The treatment method is as follows: extract lymphocytes from the patient's husband or a third individual, inject them subcutaneously into the patient's forearm, induce the patient to produce blocking antibodies against the husband's individual genes, inhibit the immune rejection reaction between mother and child, and achieve the purpose of reducing the abortion rate. However, this method has been reported to have the risk of cross-infection, and some patients have even been infected with certain infectious diseases, so a more suitable method is urgently needed.
[0005] Traditional Chinese medicine has certain advantages in the treatment of blocked antibody lesions. It can not only regulate the physiological stimulation of CD3, CD4, and CD8 antigens in patients with blocked antibody lesions through multiple pathways and targets, but also has few side effects, no drug dependence, and good safety. Summary of the invention
[0006] The purpose of the present invention is to provide a Chinese medicine composition and a pharmaceutical preparation thereof with small side effects for treating habitual abortion, especially habitual abortion caused by abnormal blocking antibodies, as well as the use of the Chinese medicine composition or the pharmaceutical preparation in the preparation of a medicine for treating habitual abortion caused by abnormal blocking antibodies.
[0007] The inventor found in long-term clinical practice that habitual abortion belongs to the category of "slippery abortion" and "infertility" in traditional Chinese medicine, and is mostly related to kidney deficiency, blood deficiency, qi stagnation and blood stasis. The basic pathogenesis of recurrent spontaneous abortion with blocking antibody deficiency is kidney and spleen yang deficiency, insufficient qi and blood, and instability of Chong and Ren meridians, which are often accompanied by soreness of waist and knees, dizziness and tinnitus, sallow complexion, fear of cold and cold limbs, lower abdomen falling, poor appetite and loose stools, shortness of breath, fatigue and laziness, and deep and slow pulse. The treatment should be based on warming the kidney and spleen, replenishing qi and nourishing blood, and regulating Chong and Ren meridians. Traditional Chinese medicine has a good immune regulation effect, and traditional Chinese medicine has a long history of treating abortion with fetal preservation and recognized efficacy.
[0008] In a first aspect of the present invention, a Chinese medicine composition for treating abnormal blocking antibodies is provided, wherein the Chinese medicine composition is composed of the following raw materials in parts by weight:
[0009] 12-18 parts of Eucommia ulmoides, 10-14 parts of Rehmannia glutinosa, 10-14 parts of Cuscuta australis, 13-17 parts of Epimedium brevicornum, 10-14 parts of Angelica sinensis, 13-18 parts of roasted Astragalus membranaceus, 10-14 parts of Chuanxiong, and 10-14 parts of Perilla stem.
[0010] Furthermore, the preferred traditional Chinese medicine composition of the present invention is composed of the following raw materials in parts by weight: 15 parts of Eucommia ulmoides, 12 parts of Rehmannia glutinosa, 12 parts of Cuscuta australis, 15 parts of Epimedium brevicornum, 12 parts of Angelica sinensis, 15 parts of roasted Astragalus membranaceus, 12 parts of Ligusticum chuanxiong, and 12 parts of Perilla stem.
[0011] In the Chinese medicine composition, the main drug is Eucommia ulmoides, the assistant drug is Cuscuta chinensis, and Rehmannia glutinosa and Chuanxiong are adjuvants. In the prescription of the present invention, Epimedium brevicornum is paired with Eucommia ulmoides to nourish the liver and kidney, warm yang and stabilize the fetus; Rehmannia glutinosa is paired with Cuscuta chinensis to nourish the liver and kidney, nourish blood and nourish yin, and the four medicines have the effects of nourishing the liver and kidney, nourishing blood and stabilizing the fetus. However, this disease is not a simple deficiency syndrome, and it can be tonified by regulating qi and activating blood circulation. It is still necessary to pair Angelica sinensis, Chuanxiong, and Perilla frutescens stem to promote qi and activate blood circulation. Perilla frutescens stem regulates qi and relieves middle pain, relieves pain and stabilizes the fetus; Angelica sinensis replenishes blood and activates blood circulation, regulates menstruation and relieves pain; Chuanxiong activates blood circulation and promotes qi circulation, dispels wind and relieves pain. Chuanxiong is paired with Perilla frutescens stem to regulate qi and activate blood circulation; Angelica sinensis replenishes blood and activates blood circulation. All the medicines match, play the role of promoting qi and activating blood circulation, nourishing the liver and kidney, nourishing yin and strengthening yang, nourishing blood and stabilizing the fetus, and are clinically used to treat habitual abortion, and have achieved satisfactory results.
[0012] The second aspect of the present invention provides a pharmaceutical preparation having the above-mentioned Chinese medicine composition for treating abnormal blocking antibodies as an active ingredient. The pharmaceutical preparation is prepared into a commonly used dosage form in pharmacy by conventional preparation methods in the art.
[0013] The pharmaceutical preparation for treating abnormal blocking antibodies as an active ingredient is in the form of granules, tablets, granules, powders, capsules, oral liquids or drop pills.
[0014] Furthermore, the pharmaceutical preparation of the present invention can be prepared by the following method:
[0015] (A) weighing each medicinal material component, mixing them, soaking them in a container for a certain period of time, boiling them under normal pressure, filtering out the medicinal liquid, and obtaining a water extract of the Chinese medicine composition;
[0016] (B) A pharmaceutically acceptable carrier is added to the water extract and prepared by a conventional preparation method in the art.
[0017] The dosage of the present invention is a therapeutically effective amount, for example, about 2 g / kg body weight to about 5.5 g / kg body weight per day, and a preferred dosage is about 3 g / kg body weight to about 4 g / kg body weight. The administration time should take into account the route of administration and the patient's health status, which are all within the skill range of skilled physicians.
[0018] In addition, the Chinese medicine composition of the present invention can be used as the sole active ingredient to treat blocking antibody abnormalities, and can also be used in combination with other therapeutic agents, such as compound betamethasone injection, etc.
[0019] Functions and Effects of the Invention
[0020] The Chinese medicine composition for treating abnormal blocking antibodies provided by the present invention has low-cost raw materials, is simple to prepare, convenient to use, has little side effects, and has good efficacy in treating abnormal blocking antibodies after many years of clinical application and pharmacological research, with an effective rate of 94%. The Chinese medicine compound preparation of the present invention has good application prospects and provides a new treatment idea for habitual abortion caused by abnormal blocking antibodies. DETAILED DESCRIPTION
[0021] The present invention is now described in detail with reference to embodiments, but the implementation of the present invention is not limited thereto.
[0022] The experimental methods in the following examples that do not specify specific conditions are usually carried out under conventional conditions or under conditions recommended by the manufacturer. The medicinal materials used in the examples of the present invention can be obtained from Chinese medicinal material sales companies unless otherwise specified. The medicinal materials obtained are Chinese medicinal material slices unless otherwise specified. The slices can be obtained from sales companies or processed after being obtained.
[0023] Example 1: Preparation of decoction of Chinese medicine composition
[0024] Weigh 15 parts by weight of Eucommia ulmoides, 12 parts by weight of Rehmannia glutinosa, 12 parts by weight of Cuscuta australis, 15 parts by weight of Epimedium brevicornum, 12 parts by weight of Angelica sinensis, 15 parts by weight of roasted Astragalus membranaceus, 12 parts by weight of Ligusticum chuanxiong, and 12 parts by weight of Perilla stem.
[0025] After washing with water, soaking in a container for more than 2 hours, boiling at normal pressure for 60 minutes, filtering out the medicinal liquid, and obtaining the water decoction of the Chinese medicine composition of the present invention, and then packaging.
[0026] Example 2: Preparation of granules of Chinese medicine composition
[0027] Weigh 15 parts by weight of Eucommia ulmoides, 12 parts by weight of Rehmannia glutinosa, 12 parts by weight of Cuscuta australis, 15 parts by weight of Epimedium brevicornum, 12 parts by weight of Angelica sinensis, 15 parts by weight of roasted Astragalus membranaceus, 12 parts by weight of Ligusticum chuanxiong, and 12 parts by weight of Perilla stem.
[0028] After washing with water, soak in a container for more than 2 hours, decoct at normal pressure for 60 minutes, filter out the medicinal liquid to obtain the water extract of the Chinese medicine composition of the present invention, add dextrin and powdered sugar after concentration, mix well, make a soft material with an appropriate amount of 70% ethanol, granulate through a No. 1 sieve, dry at 50°C for 2 hours, sieve the dried granules through a 12-14 mesh sieve, and package to obtain.
[0029] Example 3: Preparation of tablets of Chinese medicine composition
[0030] Weigh 15 parts by weight of Eucommia ulmoides, 12 parts by weight of Rehmannia glutinosa, 12 parts by weight of Cuscuta australis, 15 parts by weight of Epimedium brevicornum, 12 parts by weight of Angelica sinensis, 15 parts by weight of roasted Astragalus membranaceus, 12 parts by weight of Ligusticum chuanxiong, and 12 parts by weight of Perilla stem.
[0031] After washing with water, soak in a container for more than 2 hours, decoct at normal pressure for 60 minutes, filter out the medicinal liquid to obtain the water extract of the Chinese medicine composition of the present invention, add microcrystalline cellulose and starch to mix, add an appropriate amount of 70% ethanol to make a soft material, sieve through No. 1 sieve to granulate, dry at 50°C for 2 hours, sieve the dried granules through a 12-14 mesh sieve to size the granules, add magnesium stearate, mix well, and press into tablets to obtain the water extract.
[0032] Example 4: Clinical Observation Effect
[0033] Case source: The cases were collected from outpatients who visited the Department of Integrated Traditional Chinese and Western Medicine, Department of Obstetrics and Gynecology, Fudan University Affiliated Hospital between January 2020 and December 2022 with complaints of recurrent spontaneous abortion and history of spontaneous abortion.
[0034] Inclusion criteria:
[0035] 1. Cases with a clear diagnosis of abnormal blocking antibodies confirmed by blocking antibody immunological testing.
[0036] 2. Receive standardized traditional Chinese medicine treatment (treatment time ≥ 6 months);
[0037] 3. The clinical relevant data are basically complete.
[0038] Exclusion criteria:
[0039] 1. The treatment and medication are not standardized, and the treatment time is less than 6 months.
[0040] 2. Patients with serious underlying diseases such as heart, brain, lung, kidney, stomach, liver and tumors have an expected survival period of less than 6 months.
[0041] 3. During the treatment process, other diseases are newly diagnosed, such as ectopic pregnancy, tumors, blood diseases, renal insufficiency, liver cirrhosis, gastrointestinal bleeding, etc.
[0042] Treatment method: The Chinese medicine group was treated with the Chinese medicine composition decoction in Example 1 of the present invention, with one dose per day, decocted in water, about 500 mL, taken twice a day in the morning and evening, 28 days as a course of treatment, and 6 courses of treatment were taken continuously. The control group was observed without drug treatment or treated with cyclosporine.
[0043] Evaluation criteria: (1) Treatment effectiveness: Cure: The blocking antibody test is normal, and the intrauterine pregnancy is live until delivery; Improvement: The blocking antibody test indicators are better than before, and the intrauterine pregnancy is live until delivery; Ineffectiveness: The blocking antibody test is abnormal, and spontaneous abortion still occurs.
[0044] Efficacy observation:
[0045] The 62 patients included according to the above criteria were treated with the Chinese medicine composition decoction in Example 1 of the present invention. The patients were given one dose per day, decocted in water, about 500 ml, taken twice a day in the morning and evening, 28 days as a course of treatment, and taken for 6 courses in succession. At the same time, a control study was conducted on 68 patients who did not take Chinese medicine. The clinical efficacy of the two groups was compared and observed.
[0046] The clinical efficacy of the patients before and after treatment was observed (see Table 1), and the diagnosis and treatment effect was judged by a pre- and post-treatment comparison method.
[0047] Table 1 Comparison of clinical efficacy between the two groups (n[%])
[0048]
[0049] Compared with the control group Δ P<0.05; *P<0.01
[0050] Clinical efficacy observation shows that after intervention with the Chinese medicine composition of the present invention, the blocking antibody detection index and live fetal rate of patients with abnormal blocking antibodies are improved to a certain extent, indicating that the Chinese medicine composition of the present invention has a certain therapeutic effect on patients with abnormal blocking antibodies.
[0051] Example 5: Classic case of the present invention
[0052] The patient, female, 33 years old, 0-0-2-0. The patient had two miscarriages after marriage, in November 2017 and July 2018, both of which were spontaneous abortions at more than 50 days of pregnancy. The chromosome examination of the couple was normal, and modern medical examinations indicated that the mother lacked blocking antibodies (blocking antibody efficiency -85.5, unique antibody -83.6). Usually, the secretion is yellow and thick, sometimes accompanied by lower abdominal distension and discomfort, regular menstruation, small menstrual flow, and clean in 3 days, dark in color. The stool is formed and dry every other day. Recently, she has miscarried again, and she is depressed and anxious, pale, and in poor spirits. The tongue is slightly red with thin white fur, and the pulse is thin and soft. This is due to kidney deficiency and liver depression, blood stasis and heat, deficiency of the body and excess of evil. It is intended to strengthen the body and eliminate evil at the same time. First, invigorate qi and strengthen the body, clear heat and remove blood stasis. After following this method for about four months, the leucorrhea was significantly reduced, the feeling of heaviness and distension on both sides of the lower abdomen disappeared, the spirit was slightly improved, the basal body temperature was biphasic, and the high temperature phase lasted for 9-10 days. The blocking antibody efficiency was 61.10 and the idiotypic antibody was 8.70 after rechecking. The original method was used for another two months.
[0053] On March 15, 2020, she was re-examined and complained that her menstruation was still smooth, with a slightly increased amount and red color, and it was clear in 5 days. She had a slight vaginal discharge, which was light yellow in color, but she had no other complaints. The tongue was red with a thin white coating and a fine pulse. She planned to cultivate her essence again and choose a date to prepare for pregnancy. She was re-examined on June 14, 2020, and her BBT had a high temperature for 12 days. On July 8, 2020, she was re-examined and her blood HCG was 707.67mIU / ml and P was 17.21ng / ml. She had a little blood drip every morning, and she had a slight backache. She was afraid of fetal death and was emotionally nervous. The coating was thin and white, the tongue was slightly red, and the pulse was thin and smooth. She had aborted twice, so she should be careful to prevent it. She planned to tonify the kidney and replenish qi, nourish blood and activate blood circulation, and stabilize the fetus and stop leakage. On July 22, blood HCG was 95264mIU / ml, P 35.23ng / ml, ultrasound showed that the embryo was 4mm, and fetal heart rate was seen. The Zongyuan method was used to preserve the fetus. On August 17, ultrasound showed that the embryo was 29mm, and fetal heart rate was (+). Follow-up was until March 6, 2021, when a girl was born naturally.
[0054] For patients with miscarriage, the cause must be found out, and a comprehensive examination must be done before the next pregnancy to prevent the disease before it occurs. After pregnancy, it is advisable to maintain a happy mood, eliminate worries and fears, and avoid overwork. Western medical examinations of the patient in this case showed that the mother lacked blocking antibodies, that is, the mother's immune protection of the embryo was insufficient, so the fetus was attacked by the mother's immune system, and she had repeated miscarriages.
[0055] The uterine vessels are connected to the kidneys, and both the Chong and Ren meridians originate in the uterus. The fetus is inside the mother's body, and it depends entirely on the mother's kidney qi to connect it and the Chong and Ren yin blood to nourish it. If the mother's kidney qi is sufficient and the Chong and Ren qi and blood are harmonious, the fetus will be solid and the mother will be safe. Therefore, this case is to "pre-cultivate its essence" before pregnancy. The pathogenesis of this case can be summarized as kidney deficiency and blood stasis. Following the theory of traditional Chinese medicine that "there is a reason for no death, and there is no death", before pregnancy, it is planned to nourish the kidney and replenish qi to consolidate Chong, nourish blood, activate blood circulation and remove blood stasis; after pregnancy, it is planned to nourish the kidney and replenish qi, nourish blood, activate blood circulation, stabilize the fetus and stop leakage, and prevent problems before they happen.
[0056] The above shows and describes the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments. The above embodiments and descriptions are only for explaining the principles of the present invention. The present invention may be subject to various changes and improvements without departing from the spirit and scope of the present invention. These changes and improvements fall within the scope of the present invention. The scope of protection of the present invention is defined by the attached claims and their equivalents.
Claims
1. A Chinese medicine composition for treating abnormal blocking antibodies, characterized in that: The traditional Chinese medicine composition is composed of the following raw materials in parts by weight: 12-18 parts of eucommia bark, 10-14 parts of rehmannia root, 10-14 parts of dodder seeds, 13-17 parts of epimedium, 10-14 parts of angelica, 13-18 parts of roasted astragalus, 10-14 parts of ligusticum chuanxiong and 10-14 parts of perilla stem.
2. A Chinese medicine composition for treating abnormal blocking antibodies according to claim 1, characterized in that: The traditional Chinese medicine composition is composed of the following raw materials in parts by weight: 15 parts of eucommia bark, 12 parts of rehmannia root, 12 parts of dodder seeds, 15 parts of epimedium, 12 parts of angelica, 15 parts of roasted astragalus, 12 parts of ligusticum chuanxiong and 12 parts of perilla stem.
3. A pharmaceutical preparation comprising the Chinese medicine composition for treating abnormal blocking antibodies as claimed in claim 1 or 2 as an active ingredient, characterized in that: The drug preparation is prepared into a common dosage form in pharmacy by conventional preparation methods in the art.
4. The Chinese medicine composition for treating abnormal blocking antibodies according to claim 3 is used as a pharmaceutical preparation with an active ingredient, characterized in that: The pharmaceutical preparation is in the form of granules, tablets, granules, powders, capsules, oral liquids or drop pills.
5. Use of the Chinese medicine composition for treating blocking antibody abnormality according to claim 1 or 2 in the preparation of a drug for treating blocking antibody abnormality.
6. Use of the Chinese medicinal composition for treating abnormal blocking antibodies according to claim 1 or 2 in the preparation of drugs for treating habitual abortion.
Citation Information
Patent Citations
Body-building anti-abortion liquid for curing habitual abortion and method of preparing the same
CN101249240A
Traditional Chinese medicine composition for treating recurrent abortion and application thereof
CN114288346A
